The TroFuse-005 trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum ...

The TROP2-directed antibody-drug conjugate demonstrated superior efficacy over physician’s choice of chemotherapy in patients previously treated with platinum-based therapy and immunotherapy.

Merck's TroFuse-005 Trial Evaluating Sac-TMT Met Primary Endpoints of OS and PFS in Certain Patients With Advanced or ...

Merck MRK announced that the pivotal phase III TroFuse-005 study, which evaluated its pipeline candidate, sacituzumab ...

The TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) demonstrated a statistically significant ...

“Uterine cancer” is an umbrella term that covers two types of cancer: endometrial cancer and uterine sarcoma. Both types begin in the uterus. Endometrial cancer and uterine sarcoma are different types ...

May 18 (Reuters) - Merck said on Monday its experimental drug met the main goals of a late-stage trial in patients with a ...

Platinum-resistant endometrial cancer refers to cancer that keeps growing or returns within six months after treatment with platinum-based chemotherapy drugs like cisplatin or carboplatin. Several ...

Brachytherapy is an internal radiation therapy that people may have during treatment for endometrial cancer. A doctor may suggest brachytherapy after surgery or if surgery is not an option. The ...

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...